Human monoclonal antibodies ( mAbs ) <*> are likely to be the most effective therapeutic antibodies , particularly in the case of infectious diseases
generated as a result of the immune response
Human monoclonal antibodies ( mAbs ) generated as a result of the immune response are likely to be the most effective therapeutic antibodies , particularly in the case of infectious diseases against which the immune response is protective .
Human monoclonal antibodies ( mAbs ) generated as a result of the immune response are likely to be the most effective therapeutic antibodies , particularly in the case of infectious diseases against which the immune response is protective .